0001209191-23-052775.txt : 20231013
0001209191-23-052775.hdr.sgml : 20231013
20231013162534
ACCESSION NUMBER: 0001209191-23-052775
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230310
FILED AS OF DATE: 20231013
DATE AS OF CHANGE: 20231013
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: De Witte Jan
CENTRAL INDEX KEY: 0001776929
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26224
FILM NUMBER: 231325308
MAIL ADDRESS:
STREET 1: C/O RESMED INC.
STREET 2: 9001 SPECTRUM CENTER BLVD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92123
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP
CENTRAL INDEX KEY: 0000917520
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 510317849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1100 CAMPUS ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 6092750500
MAIL ADDRESS:
STREET 1: 1100 CAMPUS ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP
DATE OF NAME CHANGE: 19950614
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0508
4/A
2023-03-10
2023-03-14
0
0000917520
INTEGRA LIFESCIENCES HOLDINGS CORP
IART
0001776929
De Witte Jan
1100 CAMPUS ROAD
PRINCETON
NJ
08540
1
1
0
0
President & CEO
0
Common Stock
2023-03-11
4
M
0
205
0.00
A
5211
D
Common Stock
2023-03-11
4
F
0
205
52.87
D
5006
D
Restricted Stock Units
0.00
2023-03-11
4
M
0
205
0.00
D
Common Stock
205
99828
D
This transaction was inadvertently omitted from the Reporting Person's Form 4 filed on March 14, 2023.
The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/11/2022 which shall be delivered to the Reporting Person within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation.
Pursuant to Instruction 9 to Form 4, the Reporting Person has omitted from this amendment to the Form 4 the transaction information with respect to the other shares of the Issuer that were reported in the initial filing of the Form 4 and which are not being amended hereby.
/s/ Eric Schwartz; Attorney-in-Fact
2023-10-13